NCT03751982

Brief Summary

Compare closed-loop with open-loop application of TES to enhance slow waves of sleep.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 8, 2018

Completed
15 days until next milestone

First Posted

Study publicly available on registry

November 23, 2018

Completed
1.1 years until next milestone

Study Start

First participant enrolled

January 14, 2020

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 14, 2021

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 14, 2022

Completed
Last Updated

November 23, 2018

Status Verified

November 1, 2018

Enrollment Period

1 year

First QC Date

November 8, 2018

Last Update Submit

November 21, 2018

Conditions

Keywords

transcranial electrical stimulation

Outcome Measures

Primary Outcomes (2)

  • Slow wave amplitude

    Amplitude of slow waves of sleep

    Slow Wave Amplitude will be assessed during the night of sleep (defined as 8 hours). The dependent measure for the statistical test will be slow wave amplitude expressed per minute of stage N3 sleep for the study night.

  • Slow wave duration

    Duration of slow wave period in sleep

    Slow Wave Duration will be assessed in minutes for the night of sleep (defined as 8 hours). The dependent measure for the statistical test will be the duration (in minutes) of slow wave stage N3 sleep for the study night.

Study Arms (2)

Open-Loop

ACTIVE COMPARATOR

In this arm of this repeated measures (within subjects) design, the participants receive electrical neuromodulation (TES) that is not synchronized to their slow waves of sleep. The Transcranial Electrical Stimulation (TES) is 2 mA applied in 100 ms pulses at 0.75 Hz.

Device: Transcranial Electrical Neuromodulation (TES)

Closed-Loop

EXPERIMENTAL

In this arm of this repeated measures (within subjects) design, the participants receive electrical neuromodulation (TES) that is synchronized to their slow waves of sleep. The Transcranial Electrical Stimulation (TES) is 2 mA applied in 100 ms pulses at 0.75 Hz.

Device: Transcranial Electrical Neuromodulation (TES)

Interventions

TES phase-aligned with slow waves or not

Closed-LoopOpen-Loop

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • healthy adults

You may not qualify if:

  • persons with epilepsy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brain Electrophysiology Laboratory Company

Eugene, Oregon, 97405, United States

Location

MeSH Terms

Conditions

ParasomniasSleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Sleep Wake DisordersNervous System DiseasesMental DisordersSleep Disorders, IntrinsicDyssomnias

Central Study Contacts

Don M Tucker, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The phase alignment of the treatment is set in software and not revealed to participant or experimenter. Order of treatment is randomized and counterbalanced.
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: Within subjects comparison of two effective treatments. Order of treatment is randomized and counterbalanced.
Sponsor Type
INDUSTRY
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
CEO, Senior Scientist

Study Record Dates

First Submitted

November 8, 2018

First Posted

November 23, 2018

Study Start

January 14, 2020

Primary Completion

January 14, 2021

Study Completion

January 14, 2022

Last Updated

November 23, 2018

Record last verified: 2018-11

Data Sharing

IPD Sharing
Will not share

Locations